4.6 Article

Simultaneous downregulation of miR-21 and miR-155 through oleuropein for breast cancer prevention and therapy

期刊

JOURNAL OF CELLULAR BIOCHEMISTRY
卷 119, 期 9, 页码 7151-7165

出版社

WILEY
DOI: 10.1002/jcb.26754

关键词

anti-cancer effect; breast cancer; miRNA; miR-21; miR-155; oleuropein

资金

  1. Immunology research center, Tabriz university of medical science, Tabriz, Iran [IR.TBZMED.REC.1395.131347]

向作者/读者索取更多资源

Breast cancer (BC) is the leading cause of cancer mortality in women worldwide. It recently was proven that miRNAs play a critical role in BC development. The use of natural agents for control of cancer by modulating miRNAs is promising. Oleuropein is a natural polyphenolic agent with anti-neoplastic properties and is well tolerated by humans. This study was undertaken to determine the therapeutic effects of oleuropein through modulation of master oncomiRs (miR-21 and miR-155) in BC cells. The present study provides the first link between miRNA and oleuropein as a mechanism in BC. MCF-7 cells were tested with and without oleuropein and the cell viability, apoptosis, and migration were examined. The effect of oleuropein on miR-21 and miR-155 expression was assessed through qRT-PCR. It was found that oleuropein induced apoptosis and retarded cell migration and invasion in a dose-dependent manner in the human MCF7 BC cell line. It was observed that oleuropein significantly decreased expression of both miR-21 and miR-155 over time in a dose-dependent manner. These results demonstrate that oleuropein is a potential therapeutic and preventive agent for BC. Oleuropein exhibits an anti-cancer effect by modulation of tumor suppressor gene expression, which is targeted by oncomiRs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Reverse expression pattern of sirtuin-1 and histone deacetylase-9 in coronary artery disease

Laleh Heidari, Sayyed Mohammad Hossein Ghaderian, Milad Bastami, Shadi Hosseini, Saeed Alipour Parsa, Sahel Heidari, Hossein Jafari, Nasim Sohrabifar, Maryam Pirhoushiaran

Summary: This study evaluated the expression level, methylation profile, and polymorphisms of SIRT1 and HDAC9 genes in CAD patients. The results suggest that the expression changes of these genes may serve as potential biomarkers for CAD detection.

ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2023)

Article Oncology

Clinical and In Silico Outcomes of the Expression of miR-130a-5p and miR-615-3p in Tumor Compared with Non-Tumor Adjacent Tissues of Patients with BC

Khandan Ilkhani, Soheila Delgir, Asma Safi, Farhad Seif, Azam Samei, Milad Bastami, Mohammad Reza Alivand

Summary: The study found that miR-130a-5p is downregulated in breast cancer tissues, potentially acting as a tumor suppressor. miR-615-3p did not show significant differences between tumor and non-tumor tissues. Subgroup studies did not reveal significant correlations between the expression of these miRNAs and subfactors.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)

Review Oncology

miRNAs Modulate the Dichotomy of Cisplatin Resistance or Sensitivity in Breast Cancer: An Update of Therapeutic Implications

Asma Safi, Milad Bastami, Soheila Delghir, Khandan Ilkhani, Farhad Seif, Mohammad R. Alivand

Summary: Cisplatin is widely used for treating malignant tumors but resistance remains a major challenge. Recent studies highlight the importance of Cancer Stem Cell (CSC)-derived drug resistance, particularly in Breast Cancer Stem Cells (BCSCs) when it comes to cisplatin sensitivity. Understanding the role of miRNAs in regulating cisplatin resistance/sensitivity can lead to more effective personalized anti-cancer therapies.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)

Article Immunology

Dysregulated Expression of miR-146a and Its Associated Immune Effectors in Peripheral Blood Mononuclear Cells of Esophageal Carcinoma Patients

Ziba Nariman-Saleh-Fam, Yaser Mansoori, Zahra Saadatian, Javad Tavakkoly-Bazzaz, Abdolreza Daraei, Sepideh Zununi Vahed, Habibollah Mahmoodzadeh, Milad Bastami

Summary: This study evaluated the expression of miR-146a and its target genes in the peripheral blood mononuclear cells (PBMCs) of ESCC patients. The results showed that miR-146a was upregulated, while its target genes IRAK1 and TRAF6 were downregulated in PBMCs of ESCC patients. NF-kappa B1 and IL6 were also downregulated in PBMCs of ESCC patients. These findings suggest a downregulatory mechanism of immune responses in PBMCs of ESCC patients.

IMMUNOLOGICAL INVESTIGATIONS (2022)

Review Cell Biology

Migrasomes and exosomes; different types of messaging vesicles in podocytes

Mohammadreza Ardalan, Seyed Mahdi Hosseiniyan Khatibi, Yalda Rahbar Saadat, Milad Bastami, Ziba Nariman-Saleh-Fam, Sima Abediazar, Rovshan Khalilov, Sepideh Zununi Vahed

Summary: Podocytes are highly specialized kidney epithelial cells that can release injury-related migrasomes. pEVs, especially migrasomes, appear to be more sensitive and reliable indicators of podocyte stress and/or damage than proteinuria in the early stages of kidney diseases.

CELL BIOLOGY INTERNATIONAL (2022)

Article Medical Laboratory Technology

Potential roles of hsa_circ_000839 and hsa_circ_0005986 in breast cancer

Zahra Firoozi, Elham Mohammadisoleimani, Abbas Shahi, Hosein Mansoori, Mohammad Mehdi Naghizadeh, Milad Bastami, Ziba Nariman-Saleh-Fam, Abdolreza Daraei, Atefeh Raoofat, Yaser Mansoori

Summary: This study evaluated the expression levels of hsa_circ_0005986 and hsa_circ_000839 in tumors and adjacent normal tissues of breast cancer patients, and their associations with clinicopathological characteristics. The results showed that the expression levels of hsa_circ_0005986 and hsa_circ_000839 were lower in tumor tissues compared to adjacent tissues. The study also identified potential ceRNA networks involving these circRNAs, which included mRNAs and miRNAs with crucial roles in breast cancer.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2022)

Review Oncology

Epi-miRNAs: Regulators of the Histone Modification Machinery in Human Cancer

Deniz Mortazavi, Behnoush Sohrabi, Meysam Mosallaei, Ziba Nariman-Saleh-Fam, Milad Bastami, Yaser Mansoori, Abdolreza Daraei, Sepideh Zununi Vahed, Shadan Navid, Zahra Saadatian, Tannaz Jamialahmadi, Yong Teng, Amirhossein Sahebkar

Summary: Cancer is a major cause of death and disability worldwide. Epigenetic deregulation, particularly involving microRNAs, plays a crucial role in carcinogenesis by affecting histone modification. Understanding the role of microRNAs in histone modification machinery can lead to the identification of novel therapeutic targets and early detection strategies for better management of cancer patients.

JOURNAL OF ONCOLOGY (2022)

Review Biochemistry & Molecular Biology

Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review

Zahra Foruzandeh, Davood Ghavi Dorabadi, Farzaneh Sadeghi, Fatemeh Zeinali-Sehrig, Mohammad Zaefizadeh, Yazdan Rahmati, Mohammad Reza Alivand

Summary: Effective prognostic and diagnostic tools are urgently needed for the detection and treatment of triple-negative breast cancer. Circular RNAs have been discovered as potential biomarkers for TNBC, and they can modulate gene expression. This review summarizes the dysregulated expression of circRNAs and their diagnostic and prognostic values in TNBC.

MOLECULAR BIOLOGY REPORTS (2022)

Article Oncology

Association of miRNA targetome variants in LAMC1 and GNB3 genes with colorectal cancer and obesity

Morteza Gholami, Marziyeh Zoughi, Roobic Behboo, Reza Taslimi, Alireza Kazemeini, Milad Bastami, Shirin Hasani-Ranjbar, Bagher Larijani, Mahsa M. Amoli

Summary: This study found that variants of rs7473 and rs1547715 are associated with the risk of obesity and colorectal cancer respectively, based on their interactions with miRNAs.

CANCER MEDICINE (2022)

Article Biochemistry & Molecular Biology

Exploring the Therapeutic Potential of Fe3O4@Glu-Oleuropein Nanoparticles in Targeting KRAS Pathway-Regulating lncRNAs in Colorectal Cancer Cells

Zahra Mahdavi Niyaki, Ali Salehzadeh, Maryam Peymani, Mohammad Zaefizadeh

Summary: This study investigates the role of lncRNA in the KRAS pathway in colorectal cancer (CRC) and highlights the therapeutic potential of Fe3O4@Glu-Oleuropein. The findings provide insights into the underlying mechanisms and offer avenues for further research in targeted cancer therapies.

BIOLOGICAL TRACE ELEMENT RESEARCH (2023)

Article Neurosciences

Synthesis of Novel Magnetic Quercetin-Neuropeptide Nanocomposite as a Smart Nano-Drug Shuttle System: Investigation of Its Effect on Behavior, Histopathological Characteristics, and Expression of MAPT and APP Genes in Alzheimer's Disease Rats

Kamelia Mobasheri, Mohammad Zaefizadeh, Maryam Ghobeh, Akram Eidi

Summary: This study aims to explore the use of a neuropeptide nano shuttle to deliver quercetin to the brains of AD model rats. The results showed that the nano shuttle significantly improved the histopathology, behavioral testing, and expression of AD-related genes in the AD rats.

JOURNAL OF ALZHEIMERS DISEASE (2023)

Review Medicine, General & Internal

Microbiota and glomerulonephritis: An immunological point of view

Mohammadreza Ardalan, Elham Ahmadian, Seyed Mahdi Hosseiniyan Khatibi, Yalda Rahbar Saadat, Milad Bastami, Yasin Bagheri, Fatemeh Zununi Vahed, Mohammadali M. Shoja, Sepideh Zununi Vahed

Summary: Glomerular injury is a major cause of CKD worldwide, and it may be associated with dysbiosis of gut microbiota. Dysbiosis can activate immune responses, leading to inflammation and proteinuria in the kidneys. Therapeutic interventions through modulation of gut microbiota can be effective in treating GN.

AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2022)

Correction Cell Biology

Critical roles of long noncoding RNAs in breast cancer (vol 235, pg 5059, 2020)

Tooba Yousefi Digesaraei, Sadra Samavarchi Tehrani, Maryam Abolghasemi, Ansar Karimian, Amir Valizadeh, Niloufar Targhazeh, Milad Bastami, Farhad Jadidi-Niaragh, Mehdi Yousefi, Hossein Samadi Kafil, Maryam Majidinia, Bahman Yousefi

JOURNAL OF CELLULAR PHYSIOLOGY (2022)

暂无数据